Uganda and WHO Launch Strategies to Enhance Healthcare for Refugees and Migrants
A new report titled “Refugee and Migrant Health System Review: Challenges and Opportunities for Long-Term Health System Strengthening in Uganda” was launched on October 15 by Uganda’s Ministry of Health…
Updated Consolidated Financial Forecasts and Introduction of Core-Based Financial Reporting
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President, Toichi Takino; “the Company”) today announced that it has revised its consolidated financial forecasts for the full-year period ending March 2025 disclosed at…
Halozyme Announces Q3 2024 Financial and Operational Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) released its third-quarter 2024 financial and operational results, showcasing strong revenue growth and notable corporate developments. CEO Commentary on Performance and Growth “Our third-quarter performance…
Blueprint Medicines Q3 2024 Results & Increased Full-Year Revenue Guidance for AYVAKIT®/AYVAKYT®
Blueprint Medicines Corporation (Nasdaq: BPMC) today announced its financial results and business highlights for the third quarter ended September 30, 2024, along with updated financial guidance. Strong AYVAKIT Performance and…
Bachem’s Sustainable Approach to TIDES Manufacturing
The pharmaceutical industry is evolving toward sustainability, with increasing awareness of the need for eco-friendly practices. Therapeutic peptides and oligonucleotides (TIDES) present particular challenges due to their traditionally resource-heavy manufacturing…
18-Year-Old Pyry Shadows SVP of R&D for a Day: I Aspire to Make a Social Impact
Exciting, Challenging, and Insightful – This Is the Impression Pyry Simi, an 18-year-old from Tampere, Gained of the Pharmaceutical Industry After Spending a Day with Outi Vaarala, SVP of Innovative…
SkinSpirit and Allergan Aesthetics Team Up to Empower Girls Inc. and Women in STEM
In its sixth year of collaboration with Girls Inc., Allergan Aesthetics, a subsidiary of AbbVie, is pleased to welcome SkinSpirit, a leading provider of medical aesthetics and skincare, to its…
ScaleReady Awards G-Rex® Grant to Luminary Therapeutics
ScaleReady, in partnership with Wilson Wolf Manufacturing and Bio-Techne Corporation (NASDAQ: TECH), has announced that Luminary Therapeutics has been awarded a $300,000 G-Rex® Grant. This funding will facilitate rapid process…
Viatris Recognized on Forbes’ 2024 List of World’s Top Companies for Women
Global healthcare company Viatris has been named to Forbes’ World’s Top Companies for Women 2024 list, an honor awarded in collaboration with Statista, a leading statistics and industry ranking provider.…
Exelixis Reports Q3 2024 Financial Results and Corporate Update
Exelixis, Inc. (Nasdaq: EXEL) released its third-quarter financial results for 2024 and highlighted recent progress across key commercial, clinical, and pipeline milestones. Key Developments and Corporate Updates Pipeline and Clinical…
WHO Activates Global Health Emergency Corps for First Time in Response to Mpox Outbreak
In October 2024, the World Health Organization (WHO), alongside its partners and Member States, activated the Global Health Emergency Corps (GHEC) for the first time to support countries grappling with…
Tuberculosis Returns as Leading Infectious Disease Killer
The World Health Organization (WHO) has released its latest report on tuberculosis (TB), revealing that 8.2 million people were newly diagnosed in 2023—the highest number since WHO began tracking TB…